Speaker Profile
Daniel H. Farkas

Daniel H. Farkas PHD, HCLD, FAACC, CC, MB

Molecular Biology, Cell and Developmental Biology
Cleveland, Ohio, United States of America

Connect with the speaker?

Daniel H. Farkas, Ph.D., HCLD (ABB), CC, CLSp(MB), FACB, is Section Head of Molecular Pathology at the Cleveland Clinic and on the faculty of the Cleveland Clinic Lerner College of Medicine. Prior to that, he was Chief Clinical Laboratory Officer for Celmatix in New York City where he established its CLIA-certified, CAP-accredited genomics-of-infertility laboratory. Prior to Celmatix, Dr. Farkas was the lead laboratory director for Sequenom Laboratories with facilities in Morrisville, NC; San Diego, CA; and Grand Rapids, MI, and oversaw these molecular diagnostics laboratories committed to maternal-fetal medicine. Previously, Dr. Farkas had been Executive Director of the Center for Molecular Medicine in Grand Rapids, a collaborative genomics initiative between Spectrum Health and the Van Andel Institute. Dr. Farkas has established three hospital-based molecular diagnostics laboratories (St. Barnabas Medical Center, Livingston, NJ; Beaumont Hospital, Royal Oak, MI; and The Methodist Hospital, Houston, TX) and has done two stints in the biotechnology industry. Dr. Farkas served on the American Association for Clinical Chemistry Board of Directors from 2007-2009 and has served on three College of American Pathologists Committees, notably for nine years on the Molecular Pathology Resource Committee and currently on the Molecular Oncology Committee. Dr. Farkas was the first professional certified by the American Board of Bioanalysis (ABB) in Molecular Diagnostics (1996) and served six years on ABB's board. Dr. Farkas has been President of the Association for Molecular Pathology (AMP), its Program Chair, and is a past AMP Leadership Award winner. He is a member of the FDA Clinical and Molecular Genetics Devices Panel. He has been on the faculties of Michigan State University (MSU), Baylor College of Medicine, Weill Medical College of Cornell University, and Beaumont Hospital's Medical Technology program. Dr. Farkas earned a BS degree in Microbiology and Public Health from MSU and a Ph.D. in Cellular and Molecular Biology from the State University of New York at Buffalo. Dr. Farkas has lectured internationally and published widely on molecular diagnostics, including his latest book: “DNA From A to Z and Back Again.”
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)